Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

omega-3 ethyl ester 90

Known as: P-OM3 adjunct 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Background Oxylipins mediate inflammation, vascular tension, and more. Their presence in lipoproteins could explain why… Expand
  • table 1
  • figure 1
  • figure 2
2012
2012
The metabolic syndrome includes both dyslipidemia and impaired vascular function. Because extended-release niacin (ERN) and… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Highly Cited
2010
Highly Cited
2010
OBJECTIVE To evaluate the effects of prescription omega-3-acid ethyl esters on non-high-density lipoprotein cholesterol (HDL-C… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Highly Cited
2009
Highly Cited
2009
BACKGROUND Prescription omega-3-acid ethyl esters (P-OM3) often are used for hypertriglyceridemic patients receiving statin… Expand
2009
2009
BACKGROUND Atrial fibrillation (AF) continues to be one of the most common cardiac problems, placing an expanding burden on the… Expand
2009
2009
Abstract Background: Prescription omega-3-acid ethyl ester (P-OM3; Lovaza®) therapy is indicated for treating very high… Expand
Highly Cited
2008
Highly Cited
2008
Omega-3 fatty acids (n-3 FA) from oily fish are clinically useful for lowering triglycerides and reducing risk of heart attacks… Expand
Highly Cited
2008
Highly Cited
2008
Prescription omega-3 acid ethyl esters (P-OM3) are commonly used for treatment of very high triglyceride levels, often in… Expand
Highly Cited
2007
Highly Cited
2007
BACKGROUND Patients with elevated serum triglyceride (TG) levels often have elevations in non-high-density lipoprotein… Expand
2006
2006
The coadministration of prescription omega‐3‐acid ethyl esters (P‐OM3) with a statin may present a treatment option for patients… Expand